Crypto hoarding brings a stock pop for small firms—and in some cases shows patterns of possible insider trading

In mid-July, the stock for the cancer drug developer MEI Pharma skyrocketed. It wasn’t because the small company, first listed on the Nasdaq in 2003, had discovered a blockbuster cancer cure. Rather, MEI Pharma’s soaring share price coincided with the…
